在患有与代谢功能障碍相关的脂肪性肝病的患者中治疗Akkermansia muciniphila
Adina Ioana Mihele1,2, Liviu Lazar1,3
1Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
Journal of medicine and life
|December 4, 2024
概括
阿克尔曼西亚尼菲拉 (AM) 显示出与代谢功能障碍相关的脂肪性肝病 (MASLD) 的潜力. 虽然与ALT或AST无关,但AM与较低的GGT和改善的HDL和血糖相关,表明氧化应激减少.
科学领域:
- 微生物组研究的研究.
- 代谢障碍 代谢障碍 代谢障碍
- 肝病学 肝病学是一种肝病学.
背景情况:
- 阿克尔曼西亚菌 (AM) 是一种与宿主新陈代谢和肠道屏障功能相关的肠道细菌.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题,具有复杂的代谢基础.
研究的目的:
- 在患有MASLD.的患者中调查Akkermansia muciniphila (AM) 度和关键代谢标志物之间的关联.
主要方法:
- 分析了一组122名MASLD患者的队列.
- 进行了AM度与肝酶 (ALT,AST,GT),HDL和血糖之间的相关性分析.
主要成果:
- 在AM和ALT或AST水平之间没有发现显著的关联.
- 在AM和玛-氨基转移酶 (GGT) 之间观察到显著的负相关性.
- AM与HDL的正相关度中等,与血糖的负相关度较弱.
结论:
- 阿克尔曼西亚菌 (AM) 可能在调节MASLD患者的代谢标志物中发挥作用.
- 观察到的相关性表明AM有潜力降低氧化应激并改善MASLD中的代谢参数.
相关概念视频
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Cystic Fibrosis: Management
141
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
141


